| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |